𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Populations with high prevalence of antibody against hepatitis E virus in Israel

✍ Scribed by Karetnyi, Yuory V; Favorov, Michael O; Khudyakova, Natasha S; Bar-Shani, Shulamit; Dagan, Ron; Fields, Howard A; Mendelson, Ella

Book ID
122665707
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
319 KB
Volume
6
Category
Article
ISSN
0928-0197

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prevalence of antibodies against hepatit
Prevalence of antibodies against hepatitis A virus among new immigrants in Israel
✍ Yuory V. Karetnyi; Dr. Ella Mendelson; Eli Shlyakhov; Eithan Rubinstein; Nina Go πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 458 KB πŸ‘ 1 views

Israel, located in a region endemic for hepatitis A virus (HAW, recently absorbed a large population of immigrants who came from the former USSR. To assess the risk of high morbidity in this population a serosurvey of HAV antibodies was undertaken. Serum samples were collected from 965 new immigrant

Prevalence of antibodies against hepatit
Prevalence of antibodies against hepatitis e virus among urban and rural populations in Venezuela
✍ Dr. Flor H. Pujol; Michael O. Favorov; Teodardo Marcano; JosΓ© A. EstΓ©; Magda Mag πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 309 KB πŸ‘ 1 views

## Abstract Antibodies against hepatitis E virus (HEV) were detected in sera by a synthetic peptide‐based enzyme immunoassay (EIA) from different populations in Venezuela. Antibodies against HEV were found in 1.6% (3/184) of urban pregnant woman (Caracas), in 3.9% (8/204) of rural populations (San

Prevalence of hepatitis C virus antibodi
Prevalence of hepatitis C virus antibodies and hepatitis C virus-RNA in an urban population
✍ Dr. M. Rapicetta; A. F. Attili; A. Mele; A. de Santis; P. Chionne; K. Cristiano; πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 554 KB

## Abstract Several studies had been carried out on anti‐hepatitis C virus (HCV) prevalence in populations with blood exposure risks and in blood donors. New tests are now available which allow the in‐ vestigation to extend to other parameters such as antibody type and HCV‐RNA. In this study the p